Job Purpose:
To support the development, dissemination, and maintenance of Pricing & Market Access deliverables for in-market, launch and select key strategic product/s in early portfolio. Support market access excellence across geographies (including Asia, MEA and LatAm) by delivering market access insights, value communication, tender intelligence, and policy support that enable improved access and uptake of Sandoz biosimilars and generics
Deliverables: Country market access landscape reports, brand specific and above-brand value communication materials, Tender tracking and insights, Market deep-dive and repository, Launch and in-market price strategy, Pricing Analytics including price evolution trackers, IRP assessment, and other activities as per business requirements
Position Purpose:
To support the development, dissemination, and maintenance of Pricing & Market Access deliverables for in-market, launch and select key strategic product/s in early portfolio. Support market access excellence across geographies (including Asia, MEA and LatAm) by delivering market insights, value communication, tender intelligence, and policy support that enable improved access and uptake of Sandoz biosimilars and generics
Your key Responsibilities:
Your key responsibilities include but not limited to:
What you will bring to the role
Essential Requirements
Skills Desired
Agility, Cross-Functional Collaboration, Data Analysis, Employee Development, External Orientation, Finance, Financial Analysis, Healthcare Sector Understanding, Health Economics, Health Policy, Health Technology Assessment (HTA), Innovation, Market Access Strategy, People Management, Pricing Strategy, Public Health, Real World Evidence (RWE), Regulatory Affairs, Reimbursement Strategy, Research Methodologies, Results-Oriented, Statistical Analysis, Strategic Partnerships

Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients.
More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer.
Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion.
Read our community engagement guidelines: http://bit.ly/4ofoggc